ML17355A529

RIC Invitation Letter External Speaker 2018 Haass

ML17355A529
Person / Time
Site:	Northwest Medical Isotopes
Issue date:	12/21/2017
From:	Alexander Adams Research and Test Reactors Licensing Projects Branch
To:	Haass C Northwest Medical Isotopes
Montgomery C, NRR/DLP, 415-3398
Shared Package
ML17355A553 Pkg.	List: ML17355A529
References
CAC MF1395
Download: ML17355A529 (3)

Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 December 21, 2017 Carolyn Haass Chief Operating Officer Northwest Medical Isotopes, LLC 22500 Hope Dale Avenue Parker, CO 80138

SUBJECT:

NORTHWEST MEDICAL ISOTOPES LLC - REGULATORY INFORMATION CONFERENCE 2018 INVITATION LETTER, SPEAKER CONFIRMATION FORM, AND EXTERNAL AGREEMENT FORM (CAC MF1395)

Dear Ms. Haass:

It is my pleasure to invite you to participate as a speaker at NRCs 30th Regulatory Information Conference (RIC). The RIC will be held on March 13-15, 2018, at the Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.

This 3-day annual conference is co-sponsored by the Office of Nuclear Reactor Regulation and the Office of Nuclear Regulatory Research, and brings together more than 3,000 participants from over 30 countries representing interested parties from government, industry, international agencies, other interested stakeholders, and members of the public. The RIC fosters communication about NRC activities, and offers a valuable forum to share perspectives on technical issues and other matters facing the nuclear industry.

Your participation as a technical session panelist will bring great value to our session entitled, "Progress Toward a Reliable Domestic Supply of Molybdenum-99," which I will be chairing. The session will be held on Wednesday, March 14, 2018, from 1:30 p.m. to 3:00 p.m. We would like to give participants an opportunity to learn What improvements are underway in construction inspection procedures, operation inspection procedures, guidance, and considerations of the impact of proposed rulemakings, on potential medical isotope facilities? This session details the progress toward licensing and regulating medical isotope facilities and shares the perspectives of regulators, licensee, the Department of Energy, and other stakeholders. I am anticipating that you can speak about recent Northwest Medical Isotopes activities addressing the future domestic production of Mo-99.

I hope you are able to accept this invitation. You can find RIC-related news and up-to-date conference information by navigating from the NRCs official public website at http://www.nrc.gov/. To confirm your participation, please complete and return the enclosed Speaker Confirmation Form and External Speaker Agreement Form to Cindy Montgomery, our session coordinator, by January 5, 2018. Please contact Cindy or me if you have questions. Cindy can be reached on 301-415-3398 or cindy.montgomery@nrc.gov.

Sincerely,

/RA/

Alexander Adams, Jr., Chief Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation U.S. Nuclear Regulatory Commission Docket No. 50-609

Enclosures:

Speaker Confirmation form External Speaker Agreement form

ML17355A529 Letter; ML17355A548 / ML17355A550 Forms ML17355A553 Pkg. *concurred via email NRR-088 OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/BC NRR/DLP/PRLB/PM NAME CMontgomery AAdams CMontgomery DATE 12/21/17 12/21/2017 12/21/2017